Company intelligence / Profile preview

ApolloDx

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

ApolloDx has developed a mobile point-of-care diagnostic platform using proprietary Apollomer probes that bind to target substances in samples, with results delivered via handheld device and smartphone/tablet app analysis[5]. The technology has been licensed for food safety testing through CibusDx, which can provide results onsite within 30 minutes for pathogen detection[5].

Modalities: Aptamer
Industry: Molecular Diagnostics

Partnerships

CibusDx (licensee for food safety testing)[5]

Beyond the preview

Go deeper on ApolloDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ApolloDx.

Explore the full profile